These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7040701)

  • 21. Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage.
    de Bustros S; Glaser BM; Michels RG; Auer C
    Arch Ophthalmol; 1985 Feb; 103(2):219-21. PubMed ID: 3883968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis for post-perfusion CABG bleeding.
    Jones RE; Cohn LH
    Chest; 1990 Aug; 98(2):516-7. PubMed ID: 2376203
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate.
    Lambert CJ; Marengo-Rowe AJ; Leveson JE; Green RH; Thiele JP; Geisler GF; Adam M; Mitchel BF
    Ann Thorac Surg; 1979 Nov; 28(5):440-4. PubMed ID: 496496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of epsilon-aminocaproic acid and kurantil on gastric secretory activity].
    Fisher AA; Burba LV; Kononova VP
    Ter Arkh; 1981; 53(2):37-40. PubMed ID: 7221934
    [No Abstract]   [Full Text] [Related]  

  • 26. An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus.
    Kenning JA; Heros RC; Dujovny M; Latchaw RE; Nelson D
    Surg Neurol; 1984 Feb; 21(2):159-64. PubMed ID: 6701753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
    Schwartz BS; Williams EC; Conlan MG; Mosher DF
    Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.
    Chang JC; Kane KK
    Am J Clin Pathol; 1984 Mar; 81(3):382-7. PubMed ID: 6702732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with epsilon aminocaproic acid in persistent hematuria after renal punch biopsy].
    Gaillard L; Brugière P
    Sem Ther; 1964 Apr; 40(4):273. PubMed ID: 5878803
    [No Abstract]   [Full Text] [Related]  

  • 31. PROLONGATION OF CANINE RENAL ALLOGRAFT SURVIVAL BY EPSILON-AMINOCAPROIC ACID, AN IN VITRO INHIBITOR OF COMPLEMENT.
    ZUKOSKI CF; SACHATELLO CR; TINSLEY EA
    Surgery; 1965 Jul; 58():167-73. PubMed ID: 14305151
    [No Abstract]   [Full Text] [Related]  

  • 32. Rhabdomyolysis during treatment with epsilon-aminocaproic acid.
    Britt CW; Light RR; Peters BH; Schochet SS
    Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arteriovenous fistula and prolonged hematuria after renal biopsy: treatment with epsilon aminocaproic acid.
    Silverberg DS; Dossetor JB; Eid TC; Mant MJ; Miller JD
    Can Med Assoc J; 1974 Mar; 110(6):671-2 passim. PubMed ID: 4817213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid.
    Chowdhary UM; Carey PC; Hussein MM
    Lancet; 1979 Apr; 1(8119):741-3. PubMed ID: 85988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of epsilon-aminocaproic acid on the mineralocorticoid hypertension of the rat.
    Hartig F; Sponer G; Bartsch W; von Möllendorf E
    Exp Pathol; 1981; 19(4):199-205. PubMed ID: 7250299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation.
    Geltzeiler J; Schwartz D
    Urology; 1984 Jul; 24(1):64-6. PubMed ID: 6740850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The modification of experimental allergic encephalomyelitis with epsilon aminocaproic acid.
    Sibley WA; Kiernat J; Laguna JF
    Neurology; 1978 Sep; 28(9 Pt 2):102-5. PubMed ID: 568743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature.
    Kane MJ; Silverman LR; Rand JH; Paciucci PA; Holland JF
    Am J Med; 1988 Dec; 85(6):861-3. PubMed ID: 3057905
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental study of the prophylactic anti-influenza and interferon-inducing activity of epsilon-aminocaproic acid].
    Kremerman IB; Priĭmiagi LS; Lozitskiĭ VP; Tefanova VT
    Antibiot Khimioter; 1988 Jan; 33(1):63-7. PubMed ID: 2454085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review.
    Galassi G; Gibertoni M; Corradini L; Colombo A
    Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.